HAX-1 Regulates Cyclophilin-D Levels and Mitochondria Permeability
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
1 Metabolic Dysfunction Is Restricted to the Sciatic Nerve in Experimental
Page 1 of 255 Diabetes Metabolic dysfunction is restricted to the sciatic nerve in experimental diabetic neuropathy Oliver J. Freeman1,2, Richard D. Unwin2,3, Andrew W. Dowsey2,3, Paul Begley2,3, Sumia Ali1, Katherine A. Hollywood2,3, Nitin Rustogi2,3, Rasmus S. Petersen1, Warwick B. Dunn2,3†, Garth J.S. Cooper2,3,4,5* & Natalie J. Gardiner1* 1 Faculty of Life Sciences, University of Manchester, UK 2 Centre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK 3 Centre for Endocrinology and Diabetes, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK 4 School of Biological Sciences, University of Auckland, New Zealand 5 Department of Pharmacology, Medical Sciences Division, University of Oxford, UK † Present address: School of Biosciences, University of Birmingham, UK *Joint corresponding authors: Natalie J. Gardiner and Garth J.S. Cooper Email: [email protected]; [email protected] Address: University of Manchester, AV Hill Building, Oxford Road, Manchester, M13 9PT, United Kingdom Telephone: +44 161 275 5768; +44 161 701 0240 Word count: 4,490 Number of tables: 1, Number of figures: 6 Running title: Metabolic dysfunction in diabetic neuropathy 1 Diabetes Publish Ahead of Print, published online October 15, 2015 Diabetes Page 2 of 255 Abstract High glucose levels in the peripheral nervous system (PNS) have been implicated in the pathogenesis of diabetic neuropathy (DN). However our understanding of the molecular mechanisms which cause the marked distal pathology is incomplete. Here we performed a comprehensive, system-wide analysis of the PNS of a rodent model of DN. -
Triadin, a Linker for Calsequestrin and the Ryanodine Receptor
Triadin, a Linker for Calsequestrin and the Ryanodine Receptor Wei Guo,* Annelise 0. Jorgensen,' and Kevin P. Campbell* *Howard Hughes Medical Institute, Department of Physiology and Biophysics, University of Iowa College of Medicine, Iowa City, Iowa 52242, and *Departmentof Anatomy and Cell Biology, University of Toronto, Toronto, Ontario, Canada M5S 1A8 Introduction Protein components of the triad junction play essential roles in muscle excitation- contraction coupling (EC coupling). Considerable research has been performed on the identification and characterization of proteins that regulate calcium storage and release from the sarcoplasmic reticulum (McPherson and Campbell, 1993; Franzini- Armstrong and Jorgensen, 1994). Key proteins characterized include the dihydro- pyridine receptor; the voltage sensor and L-type calcium channel in t-tubules; the ryanodine receptor/Ca2+-releasechannel in the terminal cisternae of the sarcoplas- mic reticulum; and calsequestrin, a moderate-affinity, high-capacity calcium-bind- ing protein located in the lumen of the junctional sarcoplasmic reticulum. Study of these proteins has been instrumental to our understanding of the molecular mecha- nisms of EC coupling. Recent research from our laboratory has focused on triadin, an abundant transmembrane protein in the junctional sarcoplasmic reticulum. Here, we briefly review recent results on the structure of triadin and its interactions with other protein components of the junctional complex in skeletal and cardiac muscle. Identification of Triadin Using purified skeletal muscle triads, we generated a library of monoclonal anti- bodies against different proteins of the junctional sarcoplasmic reticulum (Camp- bell et al., 1987). Several monoclonal antibodies recognize a protein of 94 kD (now called triadin) on reducing SDS-PAGE (Fig. -
Cardiac Calsequestrin Phosphorylation and Trafficking in the Am Mmalian Cardiomyocyte Timothy Mcfarland Wayne State University
Wayne State University DigitalCommons@WayneState Wayne State University Dissertations 1-1-2011 Cardiac Calsequestrin Phosphorylation And Trafficking In The aM mmalian Cardiomyocyte Timothy Mcfarland Wayne State University Follow this and additional works at: http://digitalcommons.wayne.edu/oa_dissertations Recommended Citation Mcfarland, Timothy, "Cardiac Calsequestrin Phosphorylation And Trafficking In The aM mmalian Cardiomyocyte" (2011). Wayne State University Dissertations. Paper 176. This Open Access Dissertation is brought to you for free and open access by DigitalCommons@WayneState. It has been accepted for inclusion in Wayne State University Dissertations by an authorized administrator of DigitalCommons@WayneState. CARDIAC CALSEQUESTRIN PHOSPHORYLATION AND TRAFFICKING IN THE MAMMALIAN CARDIOMYOCYTE by TIMOTHY P. MCFARLAND DISSERTATION Submitted to the Graduate School of Wayne State University, Detroit, Michigan in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY 2011 MAJOR: PHYSIOLOGY Approved by: ____________________________________ Advisor Date ____________________________________ ____________________________________ ____________________________________ ____________________________________ © COPYRIGHT BY TIMOTHY P. MCFARLAND 2011 All Rights Reserved DEDICATION This work is dedicated to my family. To my parents and grandparents, who provided continuous support and footed the bill for the past ten years, thank you. Your investment finally paid off. And to my beautiful and patient wife Lindsay, thank you for getting me through the tough times and keeping our family afloat, I love you. ii ACKNOWLEDGEMENTS I would like to thank the members of my dissertation committee for their support and forwardness throughout this process. Your honesty and exceptional insights have helped me to develop professionally and have greatly expedited my graduation. I would especially like to thank my mentor Dr. Steven Cala for helping me to become a scientist. -
Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly
International Journal of Molecular Sciences Article Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly 1,2, 3, 1,2, Alessandra Bolotta y, Giuseppe Filardo y, Provvidenza Maria Abruzzo *, Annalisa Astolfi 4,5 , Paola De Sanctis 1, Alessandro Di Martino 6, Christian Hofer 7, Valentina Indio 4 , Helmut Kern 7, Stefan Löfler 7 , Maurilio Marcacci 8, Sandra Zampieri 9,10, 1,2, 1, Marina Marini z and Cinzia Zucchini z 1 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna School of Medicine, 40138 Bologna, Italy; [email protected] (A.B.); [email protected] (P.D.S.); [email protected] (M.M.); [email protected] (C.Z.) 2 IRCCS Fondazione Don Carlo Gnocchi, 20148 Milan, Italy 3 Applied and Translational Research Center, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; g.fi[email protected] 4 Giorgio Prodi Interdepartimental Center for Cancer Research, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy; annalisa.astolfi@unibo.it (A.A.); [email protected] (V.I.) 5 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy 6 Second Orthopaedic and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; [email protected] 7 Ludwig Boltzmann Institute for Rehabilitation Research, 1160 Wien, Austria; [email protected] (C.H.); [email protected] (H.K.); stefan.loefl[email protected] (S.L.) 8 Department of Biomedical Sciences, Knee Joint Reconstruction Center, 3rd Orthopaedic Division, Humanitas Clinical Institute, Humanitas University, 20089 Milan, Italy; [email protected] 9 Department of Surgery, Oncology and Gastroenterology, University of Padua, 35122 Padua, Italy; [email protected] 10 Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy * Correspondence: [email protected]; Tel.: +39-051-2094122 These authors contributed equally to this work. -
Intracellular Calcium Dysregulation by the Alzheimer's Disease-Linked Protein Presenilin 2
International Journal of Molecular Sciences Review Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2 1,2, 1, 1,2,3 1,2, 1,2 Luisa Galla y, Nelly Redolfi y, Tullio Pozzan , Paola Pizzo * and Elisa Greotti 1 Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy; [email protected] (L.G.); nelly.redolfi@unipd.it (N.R.); [email protected] (T.P.); [email protected] (E.G.) 2 Neuroscience Institute, National Research Council (CNR), 35131 Padua, Italy 3 Venetian Institute of Molecular Medicine (VIMM), 35131 Padua, Italy * Correspondence: [email protected] These authors contributed equally to this work. y Received: 17 December 2019; Accepted: 21 January 2020; Published: 24 January 2020 Abstract: Alzheimer’s disease (AD) is the most common form of dementia. Even though most AD cases are sporadic, a small percentage is familial due to autosomal dominant mutations in amyloid precursor protein (APP), presenilin-1 (PSEN1), and presenilin-2 (PSEN2) genes. AD mutations contribute to the generation of toxic amyloid β (Aβ) peptides and the formation of cerebral plaques, leading to the formulation of the amyloid cascade hypothesis for AD pathogenesis. Many drugs have been developed to inhibit this pathway but all these approaches currently failed, raising the need to find additional pathogenic mechanisms. Alterations in cellular calcium (Ca2+) signaling have also been reported as causative of neurodegeneration. Interestingly, Aβ peptides, mutated presenilin-1 (PS1), and presenilin-2 (PS2) variously lead to modifications in Ca2+ homeostasis. In this contribution, we focus on PS2, summarizing how AD-linked PS2 mutants alter multiple Ca2+ pathways and the functional consequences of this Ca2+ dysregulation in AD pathogenesis. -
Calcium Signaling, Second Edition
This is a free sample of content from Calcium Signaling, Second Edition. Click here for more information on how to buy the book. Index A ANO1, 441 ABT-199/Venetoclax, 471, 473 AP. See Action potential Action potential (AP), 407 Aquaporin, 441 Activin-A, 389 ARF1, 291 AD. See Alzheimer’s disease Arteriosclerosis. See Calcification ADAM10, 551 ASD. See Autism spectrum disorder Addiction. See Drug addiction Astrocyte Adenylyl cyclase, CRAC channel calcium brain aging modulation, 72–73 Alzheimer’s disease Aging amyloid-b effects on calcium dynamics, brain 549–550 Alzheimer’s disease astrogliopathology, 548–549 amyloid-b effects on calcium calcium signaling in astrocytes, 549–552 dynamics, 549–550 endoplasmic reticulum calcium release and astrogliopathology, 548–549 astrogliotic response, 552 calcium signaling in astrocytes, 549–552 astroglia support over life, 546–547 endoplasmic reticulum calcium release and ionic signaling and excitability, 547 astrogliotic response, 552 physiology in aging, 547–548 astrocyte transcription-dependent metabolic plasticity, 391–393 astroglia support over life, 546–547 ATF3, 389 ionic signaling and excitability, 547 Atherosclerosis. See Calcification physiology in aging, 547–548 Atrap, 164 overview, 545–546 Autism spectrum disorder (ASD) tissue calcification, 534–535 IL1RAPL1 mutations, 296 AKAP9, 470 parvalbumin neurons, 228–229 AKAP79, 75 ALN, 163 B Alzheimer’s disease (AD) BAP1, 482 astrocyte aging Bcl-2 amyloid-b effects on calcium dynamics, 549–550 endoplasmic reticulum function, 465–466 astrogliopathology, -
Calsequestrin Is an Inhibitor of Skeletal Muscle Ryanodine Receptor Calcium Release Channels
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector 310 Biophysical Journal Volume 82 January 2002 310–320 Calsequestrin Is an Inhibitor of Skeletal Muscle Ryanodine Receptor Calcium Release Channels Nicole A. Beard,* Magdalena M. Sakowska,† Angela F. Dulhunty,* and Derek R. Laver† *Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research and †School of Biochemistry and Molecular Biology, The Faculties, Australian National University, Canberra, ACT 0200, Australia ABSTRACT We provide novel evidence that the sarcoplasmic reticulum calcium binding protein, calsequestrin, inhibits native ryanodine receptor calcium release channel activity. Calsequestrin dissociation from junctional face membrane was achieved by increasing luminal (trans) ionic strength from 250 to 500 mM with CsCl or by exposing the luminal side of ryanodine receptors to high [Ca2ϩ] (13 mM) and dissociation was confirmed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. Calsequestrin dissociation caused a 10-fold increase in the duration of ryanodine receptor channel opening in lipid bilayers. Adding calsequestrin back to the luminal side of the channel after dissociation reversed this increased activity. In addition, an anticalsequestrin antibody added to the luminal solution reduced ryanodine receptor activity before, but not after, calsequestrin dissociation. A population of ryanodine receptors (ϳ35%) may have initially lacked calsequestrin, because their activity was high and was unaffected by increasing ionic strength or by anticalsequestrin antibody: their activity fell when purified calsequestrin was added and they then responded to antibody. In contrast to native ryanodine receptors, purified channels, depleted of triadin and calsequestrin, were not inhibited by calsequestrin. -
Alterations of Protein Expression of Phospholamban, ZASP And
www.nature.com/scientificreports OPEN Alterations of protein expression of phospholamban, ZASP and plakoglobin in human atria in Received: 29 May 2018 Accepted: 22 March 2019 subgroups of seniors Published: xx xx xxxx Ulrich Gergs 1, Winnie Mangold1, Frank Langguth1, Mechthild Hatzfeld2, Stefen Hauptmann3, Hasan Bushnaq4, Andreas Simm4, Rolf-Edgar Silber4 & Joachim Neumann1 The mature mammalian myocardium contains composite junctions (areae compositae) that comprise proteins of adherens junctions as well as desmosomes. Mutations or defciency of many of these proteins are linked to heart failure and/or arrhythmogenic cardiomyopathy in patients. We frstly wanted to address the question whether the expression of these proteins shows an age- dependent alteration in the atrium of the human heart. Right atrial biopsies, obtained from patients undergoing routine bypass surgery for coronary heart disease were subjected to immunohistology and/or western blotting for the plaque proteins plakoglobin (γ-catenin) and plakophilin 2. Moreover, the Z-band protein cypher 1 (Cypher/ZASP) and calcium handling proteins of the sarcoplasmic reticulum (SR) like phospholamban, SERCA and calsequestrin were analyzed. We noted expression of plakoglobin, plakophilin 2 and Cypher/ZASP in these atrial preparations on western blotting and/or immunohistochemistry. There was an increase of Cypher/ZASP expression with age. The present data extend our knowledge on the expression of anchoring proteins and SR regulatory proteins in the atrium of the human heart and indicate an age-dependent variation in protein expression. It is tempting to speculate that increased expression of Cypher/ZASP may contribute to mechanical changes in the aging human myocardium. Aging represents an important risk factor for the development of cardiovascular diseases like heart failure. -
Membrane Segregation and Downregulation of Raft Markers During Sarcolemmal Differentiation in Skeletal Muscle Cells
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Available online at www.sciencedirect.com R Developmental Biology 262 (2003) 324–334 www.elsevier.com/locate/ydbio Membrane segregation and downregulation of raft markers during sarcolemmal differentiation in skeletal muscle cells A. Draeger,a,* K. Monastyrskaya,a F.C. Burkhard,b A.M. Wobus,c S.E. Moss,d and E.B. Babiychuka,e a Department of Cell Biology, Institute of Anatomy, University of Bern, Switzerland b Department of Urology, University Hospital of Bern, Switzerland c In Vitro Differentiation Group, Institute of Plant Genetics and Crop Plant Research, Gatersleben, Germany d Department of Cell Biology, Institute of Ophthalmology, University College, London e The Institute of Physiology, Kiev Taras Schevchenko University, Ukraine Received for publication 24 April 2003, accepted 16 June 2003 Abstract Muscle contraction implies flexibility in combination with force resistance and requires a high degree of sarcolemmal organization. Smooth muscle cells differentiate largely from mesenchymal precursor cells and gradually assume a highly periodic sarcolemmal organization. Skeletal muscle undergoes an even more striking differentiation programme, leading to cell fusion and alignment into myofibrils. The lipid bilayer of each cell type is further segregated into raft and non-raft microdomains of distinct lipid composition. Considering the extent of developmental rearrangement in skeletal muscle, we investigated sarcolemmal microdomain organization in skeletal and smooth muscle cells. The rafts in both muscle types are characterized by marker proteins belonging to the annexin family which localize to the inner membrane leaflet, as well as glycosyl-phosphatidyl-inositol (GPI)-anchored enzymes attached to the outer leaflet. -
Calsequestrin Interacts Directly with the Cardiac Ryanodine Receptor Luminal Domain Ahmed Handhle1,2,*, Chloe E
© 2016. Published by The Company of Biologists Ltd | Journal of Cell Science (2016) 129, 3983-3988 doi:10.1242/jcs.191643 SHORT REPORT Calsequestrin interacts directly with the cardiac ryanodine receptor luminal domain Ahmed Handhle1,2,*, Chloe E. Ormonde1,*, N. Lowri Thomas1, Catherine Bralesford1, Alan J. Williams1, F. Anthony Lai1 and Spyros Zissimopoulos1,‡ ABSTRACT both dominant and recessive mutations of calsequestrin 2 (CSQ2) Cardiac muscle contraction requires sarcoplasmic reticulum (SR) (http://triad.fsm.it/cardmoc/). Ca2+ release mediated by the quaternary complex comprising the RyR2 exists as a macromolecular complex composed of CSQ2 ryanodine receptor 2 (RyR2), calsequestrin 2 (CSQ2), junctin (encoded and the SR integral membrane proteins triadin and junctin (encoded ASPH 2+ by ASPH) and triadin. Here, we demonstrate that a direct interaction by ), which together form the luminal Ca sensor (Zhang exists between RyR2 and CSQ2. Topologically, CSQ2 binding occurs et al., 1997). CSQ2 interacts directly with both triadin and junctin in 2+ – 2+ at the first luminal loop of RyR2. Co-expression of RyR2 and CSQ2 in aCa -dependent manner, with 1 5mMCa inhibiting these a human cell line devoid of the other quaternary complex proteins interactions (Shin et al., 2000; Zhang et al., 1997). Their binding results in altered Ca2+-release dynamics compared to cells expressing sites have been mapped to the Asp-rich region at the C-terminus of – RyR2 only. These findings provide a new perspective for understanding CSQ2 and to the KEKE motif (residues 200 224) of triadin the SR luminal Ca2+ sensor and its involvement in cardiac physiology (Kobayashi et al., 2000; Shin et al., 2000). -
Chapter 4 Calsequestrin
Chapter 4 Calsequestrin DAVID H. MacLENNAN Banting and Best Department of Medical Research C. H. Best Institute, University of Toronto Toronto, Ontario, Canada KEVIN P. CAMPBELL Department of Physiology and Biophysics University of Iowa Iowa City, Iowa and REINHART A. F. REITHMEIER Department of Biochemistry University of Alberta Edmonton, Alberta, Canada I. Sarcoplasmic Reticulum ............................................................................. 152 II. Isolated Sarcoplasmic Reticulum Vesicles ................................................. 153 III. Isolation of Calsequestrin ........................................................................... 155 IV. Ca2+ Binding by Calsequestrin ................................................................... 155 V. Size and Shape of Calsequestrin................................................................. 157 VI. Amino Acid Sequence................................................................................ 159 VII. Carbohydrate Content................................................................................. 160 VIII. Stains-All Staining...................................................................................... 160 IX. Properties of Calsequestrin in Other Muscles............................................. 161 X. Phosphorylation of Calsequestrin ............................................................... 162 XI. Localization of Calsequestrin ..................................................................... 163 XII. Biosynthesis............................................................................................... -
(CASQ1) Gene on Chromosome 1Q21 Is Associated with Type 2 Diabetes in the Old Order Amish Mao Fu,1,2 Coleen M
Polymorphism in the Calsequestrin 1 (CASQ1) Gene on Chromosome 1q21 Is Associated With Type 2 Diabetes in the Old Order Amish Mao Fu,1,2 Coleen M. Damcott,1 Mona Sabra,1 Toni I. Pollin,1 Sandra H. Ott,1 Jian Wang,1 Michael J. Garant,1 Jeffrey R. O’Connell,1 Braxton D. Mitchell,1 and Alan R. Shuldiner1,3 Calsequestrin (CASQ)1 is involved in intracellular stor- age and release of calcium, a process that has been shown to mediate glucose transport in muscle. Its gene, ype 2 diabetes is a common heterogeneous dis- CASQ1, is encoded on chromosome 1q21, a region that order in which genetic and nongenetic factors has been linked to type 2 diabetes in the Amish and (i.e., excess caloric intake and physical inactiv- several other populations. We screened all 11 exons, Tity) potently influence risk (1,2). Genome-wide exon-intron junctions, and the proximal regulatory re- scans have led to the chromosomal localization of suscep- gion of CASQ1 for mutations. We detected four novel tibility loci for type 2 diabetes, with the most promising ,(single nucleotide polymorphisms (SNPs) (؊1470C3T, and replicated findings on chromosomes 1q21-q24 (3–10 .(؊1456delG, ؊1366insG, and 593C3T). Ten informative 2q37 (11), 12q24 (12–14), and chromosome 20 (15–18 SNPs within CASQ1 were genotyped in Amish subjects Consistent with current thinking, multiple linked regions ؍ with type 2 diabetes (n 145), impaired glucose toler- suggest that several susceptibility genes contribute to the .(358 ؍ and normal glucose tolerance (n ,(148 ؍ ance (n development of type 2 diabetes (2).